We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
+25.15%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$8.17B
AUM Growth
+$2.55B
Cap. Flow
+$12.3M
Cap. Flow %
0.15%
Top 10 Hldgs %
61.52%
Holding
432
New
171
Increased
73
Reduced
69
Closed
99

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$36.5M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$36.1M
3
SNY icon
Sanofi
SNY
+$34.1M
4
CYTK icon
Cytokinetics
CYTK
+$31.4M
5
WAT icon
Waters Corp
WAT
+$25.6M

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$147M
2
PTCT icon
PTC Therapeutics
PTCT
+$72.4M
3
IMVT icon
Immunovant
IMVT
+$55.7M
4
DDOG icon
Datadog
DDOG
+$31.8M
5
AVNS
Avanos Medical
AVNS
+$28M

Sector Composition

Rank Sector Weight
1 Miscellaneous 55.89%
2 Healthcare 30.09%
3 Technology 6.58%
4 Consumer Discretionary 3.42%
5 Communication Services 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MOS icon
226
The Mosaic Company
MOS
$8.22B
$417K 0.01%
+19,684
New +$455K
DY icon
227
Dycom Industries
DY
$9.06B
$408K 0.01%
806
-59
-7% -$25.8K
REYN icon
228
Reynolds Consumer Products
REYN
$4.61B
$400K ﹤0.01%
+14,895
New +$332K
KHC icon
229
Kraft Heinz
KHC
$29.5B
$392K ﹤0.01%
+16,593
New +$383K
MDT icon
230
Medtronic
MDT
$120B
$387K ﹤0.01%
+4,947
New +$399K
CE icon
231
Celanese
CE
$4.9B
$379K ﹤0.01%
+8,232
New +$476K
NVT icon
232
nVent Electric
NVT
$25.3B
$376K ﹤0.01%
+2,214
New +$345K
COST icon
233
Costco
COST
$406B
$372K ﹤0.01%
+398
New +$397K
SN icon
234
SharkNinja
SN
$24.4B
$370K ﹤0.01%
+2,431
New +$291K
EAT icon
235
Brinker International
EAT
$9.62B
$369K ﹤0.01%
+2,198
New +$325K
CPAY icon
236
Corpay
CPAY
$27.3B
$367K ﹤0.01%
+1,100
New +$365K
LYB icon
237
LyondellBasell Industries
LYB
$20.5B
$365K ﹤0.01%
+6,931
New +$478K
BESS.WS
238
Bimergen Energy Corp Warrants
BESS.WS
$356K ﹤0.01%
187,500
– –
LZ icon
239
LegalZoom.com
LZ
$1.05B
$346K ﹤0.01%
+56,391
New +$346K
BX icon
240
Blackstone
BX
$102B
$333K ﹤0.01%
+2,826
New +$340K
MKC icon
241
McCormick & Company Non-Voting
MKC
$14B
$331K ﹤0.01%
+6,570
New +$322K
FTDR icon
242
Frontdoor
FTDR
$5.69B
$329K ﹤0.01%
+4,243
New +$271K
LECO icon
243
Lincoln Electric
LECO
$15.1B
$325K ﹤0.01%
+1,223
New +$320K
INBS icon
244
Intelligent Bio Solutions
INBS
$6.75M
$325K ﹤0.01%
141,397
+11,397
+9% +$30K
GM icon
245
General Motors
GM
$77B
$322K ﹤0.01%
+4,172
New +$328K
MC icon
246
Moelis & Co
MC
$5.11B
$319K ﹤0.01%
+4,877
New +$320K
APA icon
247
APA Corp
APA
$15B
$310K ﹤0.01%
+9,521
New +$358K
VEEV icon
248
Veeva Systems
VEEV
$44.5B
$309K ﹤0.01%
+1,740
New +$287K
VNOM icon
249
Viper Energy
VNOM
$15.9B
$309K ﹤0.01%
+7,282
New +$336K
SITE icon
250
SiteOne Landscape Supply
SITE
$4.39B
$299K ﹤0.01%
+2,613
New +$316K
8 9
10
11 12

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Armistice Capital held 432 positions worth $8.17B, up 45% from $5.62B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Armistice Capital's Q2 2026 filing shows 171 new, 73 increased, 69 reduced and 99 closed positions. Its largest new stake was Waters Corp: 75,004 shares worth $28.1M. The largest sale was Travere Therapeutics, an estimated $147M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 46% a quarter earlier, followed by Healthcare and Technology.

  • Armistice Capital's largest Q2 2026 buy was Waters Corp: 75,004 shares worth $28.1M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2026, an estimated $36.5M increase.
  • Armistice Capital's biggest Q2 2026 reduction was Travere Therapeutics, cutting an estimated $147M.
  • Armistice Capital fully exited Avanos Medical in Q2 2026, selling an estimated $28M.
  • Armistice Capital's ten largest holdings make up 62% of its $8.17B portfolio in Q2 2026.
  • Armistice Capital opened 171 new positions and closed 99 in Q2 2026.
  • Armistice Capital's portfolio value rose 45% quarter-over-quarter to $8.17B.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.